Sunday, September 21, 2014 4:10:29 PM
I assume you are saying this is true for Ebolacide as well as any vaccine or other treatment? Or is this a case of NNVC's superpowers and not being held to the norms of science and common sense?
The contention that NNVC is better than a vaccine or treatment because your body will be infected and therefore build up antibodies against all forms of ebola is undermined by your further contention that ebolacide can be used prophylactically.
If used prophylactically, then there will be no antibodies produced and no immunity developed. If you are suggesting a lifelong, daily regiment of ebolacide, then this MIGHT make sense. But given the reality of the circumstances and locations and cultural issues, this is not at all practical. If we are going to play the game of what if, and your starting point is what if (when) it works, then there is no limit to what could be claimed. There are numerous examples of this already from NNVC management and others, including SP predictions that are so embarrassingly unrealistic, that they are really more sad than pathetic.
And please correct me if I'm wrong, but there is no possible way that treating primates in the wild will be admissible as "proof" of NNVC's safety and efficacy and therefore will advance ebolacide towards human testing.
Even for the unrealistic and nonsensical world of NNVC this is ludicrous.
Oh, and could you remind me again, where Dr. Seymour stayed last time he was in HI? THAT'S what matters!
The SwingTrade Portfolio is up 42.1% YTD through 8/8/2014, 83.5% in 2013, and 537.4% since inception.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=105141243
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM